Foreign drug companies are rapidly increasing their share of the Indian market. Since December 2008, the number of top 10 drug firms in India controlled by foreign companies has increased from one to four. Daiichi Sankyo acquired Ranbaxy Laboratories, Sanofi-Aventis purchased Shantha Biotechnics, and Abbott Laboratories plans to acquire Piramal Healthcare. Tarun Shah of MP […]
The World Bank has approved a $100 million loan to China, its largest food safety loan to date. The money will finance 70% of the government’s Jilin Agricultural Product Quality and Safety Project. Located in northeast China, Jilin province is a major supplier of agriculture to the country. The Project is designed to improve product […]
Rapidly growing US sales of oncology drugs is making the sector a focus of drug development. Approximately 40% of the estimated 40,000 drugs in Phase I, II or III trials are cancer related. US sales of oncology drugs, excluding hormonal therapies and vaccines, increased 10.8% in 2009 to $18.5 billion. US sales of targeted cancer […]
According to Food Processing magazine’s 39th Annual R&D Survey, which questioned 310 food manufacturers, R&D remains a priority. Half of those surveyed chose “new product development” as the most important target for their companies’ R&D efforts this year, followed by “existing product improvement,” which was selected by 13% of respondents. Food safety and nutrition are […]
Combined sales for the top 50 US chemical companies declined 21% to $247.5 billion in 2009, reflecting the impact of the recession. Only four firms recorded revenue increases. The companies with the highest sales were Dow Chemical, Exxon Mobil, DuPont and PPG Industries, which recorded 2009 revenue changes of -22.0%, -30.1%, -14.6%, -18.3%, respectively. Sales […]
First-quarter 2009 Life Science Index sales grew 12.3%, 9.3% on a currency-neutral basis, to $2,788.36 million. Operating profit soared 27.4% to $615.14 million, while operating margin gained 270 basis points to 22.1% of sales due to product introductions and continued cost-saving initiatives. Of the 14 Index companies, Tecan was the only company for which first-quarter […]
Washington, DC 6/2/10; San Diego, CA 6/2/10—The SEC has charged Elizabeth A. Dragon, former senior vice president of R&D at Sequenom, with making false statements to investors. The statements were in connection with the genetic test that Sequenom was developing for noninvasive prenatal detection of Down’s syndrome (see IBO 9/30/09). The SEC charges that she […]
Stockholm, Sweden 5/17/10; Hopkinton, MA 5/17/10—Biotage has agreed to purchase Caliper Life Sciences’ RapidTrace and TurboVac product lines for $16.5 million in cash. In 2009, the product lines generated $9.5 million in sales. The RapidTrace SPE Workstation is a high-throughput solid phase extraction platform. The TurboVac Concentration Evaporator Workstations are microprocessor-controlled concentrators for automated sample […]
Washington, DC 6/10/10; Washington, DC 6/15/10—Certara, which Symyx Technologies has identified as the competitor that submitted a rival bid for the company (see IBO 5/31/10), has revoked its offer of $6.75 per share. Symyx stated that because there is now no superior proposal to Accelrys’s offer, it has terminated discussion with Certara.
Carlsbard, CA 5/28/10; Regensburg, Germany 5/28/10; Carlsbad, CA 6/2/10—Following the completion of its tender offer, Life Technologies has acquired a 74% stake in GENEART AG, a producer of synthetic genes (see IBO 4/30/10). “Through Life Technologies, GENEART will be able to materially expand its impact through enhanced distribution and commercial capabilities in the United States, […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
